PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Endocrinology, Affiliated Hospital of Weifang Medical University, Weifang, China.\', \'Clinical Research Center, Affiliated Hospital of Weifang Medical University, Weifang, China.\', \'Department of Pathology, Affiliated Hospital of Weifang Medical University, Weifang, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fendo.2021.708494
?:doi
?:hasPublicationType
?:journal
  • Frontiers in endocrinology
is ?:pmid of
?:pmid
?:pmid
  • 34603199
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.79
?:rankingScore_hIndex
  • 42
?:title
  • Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all